(Q53300664)

13 May 2018

title

Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults. (English)

1 reference

13 May 2018

0 references

1 reference

1 reference

8

Lisa R Bulkow

1 reference

13 May 2018

Brian J. McMahon

4

object named as

Brian J McMahon

1 reference

13 May 2018

author name string

James L Williams

1

1 reference

13 May 2018

Dana A Bruden

2

1 reference

13 May 2018

Henry H Cagle

3

1 reference

13 May 2018

Susan E Negus

5

1 reference

13 May 2018

Carol J Christensen

6

1 reference

13 May 2018

Mary M Snowball

7

1 reference

13 May 2018

Leslie K Fox-Leyva

9

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

13 May 2018

published in

Vaccine

1 reference

13 May 2018

volume

21

1 reference

13 May 2018

issue

23

1 reference

13 May 2018

page(s)

3208-3211

1 reference

13 May 2018

Immunogenicity of inactivated hepatitis A vaccine in children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Protection against hepatitis A by an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Vaccination against hepatitis A in children aged 12 to 24 months [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

A randomized study of a flexible booster dosing regimen of VAQTA in adults: safety, tolerability, and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Excellent booster response 4-6 y after a single primary dose of an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900250-0

7 January 2021

10.1016/S0264-410X(03)00250-0

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018